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Abstract
Video-assisted mini-laparotomy surgery (VAMS), a hybrid of open and laparoscopic surgical techniques, is an important surgical
approach in the ﬁeld of partial nephrectomy. The learning curve for VAMS partial nephrectomy has not been studied to date; we
therefore, evaluated this learning curve.
We prospectively evaluated 20 consecutive patients who underwent VAMS partial nephrectomy performed by a single surgeon
(YEY) between March 2015 and December 2016. The learning curve was evaluated using the cumulative summethod. The measure
of surgical performance was composed of 3 parameters (total operation time [Op time], warm ischemic time [WIT], and estimated
blood loss [EBL]).
Among the 20 patients who underwent VAMS partial nephrectomy, the mean age was 54.6 years. The mean Op time and WIT
were 172.5 and 28.8minutes, respectively. The learning curve for the Op time, WIT, and EBL consisted of 3 unique phases: phase 1
(the ﬁrst 7 cases), phase 2 (the next 5 to 7 cases), and phase 3 (all subsequent cases). Phase 1 represents the initial learning curve,
and the phase 2 plateau represents the period of expert competency. Phase 3 represents when one is competent in VAMS partial
nephrectomy.
The learning curve for VAMS partial nephrectomy is relatively short and after a learning curve of approximately 7 cases, the surgeon
became familiar with VAMS partial nephrectomy; after 12 to 14 cases, the surgeon became competent in this procedure.
Abbreviations: ASA = American Society of Anesthesiologists, BMI = body mass index, BSA = body surface area, CUSUM =
cumulative sum, EBL = estimated blood loss, LPN = laparoscopic partial nephrectomy, Op = operation, RALPN = robot-assisted
laparoscopic partial nephrectomy, VAMS = video-assisted mini-laparotomy surgery, WIT = warm ischemic time.
Keywords: cumulative sum (CUSUM), learning curve, partial nephrectomy, video-assisted mini-laparotomy surgery (VAMS)Editor: Vito Mancini.
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11. Introduction
Innovations and advancements in surgical instrumentation and
technology have improved surgical proﬁciency, and acquiring the
ability to perform such techniques is considered important for
healthcare providers. This acquisition and understanding of
new surgical techniques is represented by a learning curve.[1]
Assessment of healthcare quality has increased in importance
in medical practice, and statistical process-control methods are
used to monitor this quality.[2] The cumulative sum (CUSUM)
technique, one of the methods developed to monitor the
performance and quality of the industrial sector, was adopted
by the medical ﬁeld in the 1970s to analyze learning curves for
surgical procedures.[3–4]
Video-assisted mini-laparotomy surgery (VAMS), a hybrid of
laparoscopic and open surgical techniques, does not require gas
insufﬂation and extracts an intact solid organ through a minimal
incision.[5] Laparoscopic partial nephrectomy (LPN) is the
traditional approach and standard treatment option for most
small renal masses,[6–8] while robot-assisted laparoscopic partial
nephrectomy (RALPN) has been introduced with the goal of
reducing the learning curve for intracorporeal suturing, and
facilitating renorrhaphy.[9] Several studies have reported learning
curves for both LPN and RALPN[9–10]; however, no study has yet
reported the learning curve for VAMS partial nephrectomy since
VAMS has not been performed widely and it’s awareness is low.
We investigated the learning curve for VAMS partial nephrec-
tomy using CUSUM methodology.
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This retrospective study was conducted via medical record review
of patients at the Severance Hospital, Seoul, South Korea. The
InstitutionalReviewBoard of the Yonsei UniversityHealth System
approved the protocol for this study (project no: 4-2017-0457).
The study included 20 consecutive VAMS partial nephrectomy
surgery procedures performed between March 2015 and Decem-
ber 2016 by a single experienced urologist (YEY).
All procedureswere performed using the VAMS technique, with
the patient placed in the semilateral position. The operative space
was the retroperitoneal space, and a piercing abdominal wall
elevator, a piercing peritoneal retractor, and blades from an
external self-retaining retractor system were used. A 6- to 7-cm
transverse skin incisionmade 2 ﬁngerbreadths superior to the level
of umbilicus, beginning at the lateral border of the rectus
abdominis and extending laterally to the costal margin (Fig. 1).
A detailed description of the surgical technique has been provided
elsewhere.[11] The operation time (Op time)was deﬁned as the time
from theﬁrst incision to that of theﬁnal closure.Demographic data
were retrospectively retrieved, including patient age, gender,
height, weight, body mass index (BMI), body surface area (BSA),
American Society of Anesthesiologists (ASA) score, past history of
hypertension and diabetes mellitus, and location of kidney cancer.
Intraoperative parameters including Op time, warm ischemic time
(WIT), and estimated blood loss (EBL)were analyzed aswell as the
patient’s hospital length of stay. The RENALnephrometry score is
used to characterize a renal tumor based on tumor radius,
endophyticity level, nearness to collecting system, and location
(RENAL).[12] Computed tomography or magnetic resonance
imaging images of renal tumors were independently reviewed by
aurologist resident and a urologistwithout knowledge of each case
and those cases with disagreements were reviewed by other
urologist residents and urologists. For the parameters for surgical
performance, Op time, WIT, and EBL were used. Laboratory test
results obtained preoperatively, immediately after the procedure,
and 1 day after the procedure were included.
2.1. CUSUM analysis
Learning curve provides mathematical representation of the
learning process that takes place as operation repetition occursFigure 1. Operative setup for VAMS. VAMS
2and in our study, 3 indicators, Op time, WIT, and EBL were
evaluated. For quantitative assessment of the learning curve, the
CUSUM technique was used to analyze the 20 cases. The
CUSUM is the running total of differences between the individual
data points and the mean of all data points. Thus, CUSUM can be
performed recursively.[1] The cases were ordered chronologically,
from the earliest to the latest date of surgery. The Op time for
each case is deﬁned as xi, and the mean Op time of all the cases is
deﬁned as m. Therefore, the CUSUM at Op time n (CUSUMOTn)
is calculated as follows:
CUSUMOTn ¼
Xn
i¼1
xi m
The CUSUMOT1 of the ﬁrst case was the difference between
the Op time for the ﬁrst case and the mOT. The CUSUMOT2 of the
second case was the previous case’s CUSUMOT\ added to the
difference between the Op time for the second case and mOT. This
recursive process continued until the CUSUMOT for the last case
was calculated. Similarly, additional parameters of surgical
performance, WIT and EBL, were evaluated using CUSUM
method.
Three phases were identiﬁed by the inﬂection point of the
CUSUM curve. Phase 1 shows expected incline in CUSUM curve
which is the initial learning curve, followed by a plateau (phase 2)
which is the additional experience obtained leading the
achievement of expert competence. Then there is decline in the
plateau, which is the phase 3 being the post-learning period, as
seen in typical learning curve studies.
2.2. Statistical analysis
The results are reported as mean (standard deviation) for
continuous variables and as percentage values for categorical
variables. For the comparison of phases 1, 2, and 3, analysis
of variance was used to compare continuous variables and
chi-square test or Fisher exact test for categorical variables.
SPSS software version 23.0 (SPSS Inc, Chicago, IL) was
used for statistical analyses. All statistical tests were 2-tailed,
and a P-value <.05 was considered to indicate statistical
signiﬁcance.= video-assisted mini-laparotomy surgery.
Table 1
Characteristics of the study population.
Study population
(n=20)
Patient characteristics
Age, yr 54.6 (13.0)
Gender
Male 15 (75.0%)
Female 5 (25.0%)
Height, cm 166.5 (6.9)
Weight, kg 66.6 (8.2)
BMI, kg/m2 24.0 (2.1)
BSA, m2 1.7 (0.1)
ASA score
1 4 (20.0%)
2 9 (45.0%)
3 7 (35.0%)
HTN, n (%) 9 (45.0%)
DM, n (%) 5 (25.0%)
Kidney
Right 8 (40.0%)
Left 12 (60.0%)
RENAL score, mean 8.8
Intraoperative parameters
Op time, min 172.5 (41.3)
Warm ischemic time, min 28.8 (8.1)
EBL, cc 196.5 (209.1)
Postoperative outcomes
Tumor size, cm 3.5 (0.9)
Pathology
Clear cell 16 (80.0%)
Papillary 2 (10.0%)
Chromophobe 1 (5.0%)
Multilocular cystic 1 (5.0%)
LOS, d 5.9 (2.1)
Data are shown as mean (SD) or number of subjects (%).
ASA=American Society of Anesthesiologists, BMI=body mass index, BSA=body surface area,
DM=diabetes mellitus, EBL= estimated blood loss, HTN=hypertension, LOS= length of stay, Op=
operation.
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The baseline characteristics of the study population are presented
in Table 1. The series consisted of 15 males (75.0%) and 5
females (25.0%) with a mean age of 54.6 years. Mean BMI and
BSA were 24.0kg/m2 and 1.7m2, respectively. The median ASA
score was 2. Nine patients (45.0%) had hypertension and 5
patients (25.0%) had diabetes mellitus. The tumor was located
on the right side in 8 cases (40.0%). The mean Op time and WIT
were 172.5 and 28.8minutes, respectively. The mean EBL was
196.5cc, with a mean tumor size of 3.5cm. Clear cell type
accounted for 16 cases (80.0%). Preoperative and postoperative
serum creatinine levels were 0.9 and 1.1mg/dL, respectively, with
statistical signiﬁcant difference (P< .001).
The Op times were plotted in chronological case order (Fig. 2).
The CUSUMOT learning curve was best modeled as a second-
order polynomial with the following equation: CUSUMOT (in
minutes)=–1.24case number2+19.002case number+
62.238, which had high R2 value of 0.6098. The CUSUMOT
learning curve consisted of 3 unique phases: phase 1 (the ﬁrst 7
cases), phase 2 (the next 5 cases), and phase 3 (the ﬁnal 8 cases)
(Fig. 2). Comparisons between the 3 phases identiﬁed by
CUSUMOT analysis are presented in Tables 2 and 3. There
were no signiﬁcant differences between the different phases in3terms of patient age, gender, height, weight, BMI, BSA, ASA
score, hypertension, diabetes mellitus, RENAL score, location of
tumor, and tumor size. Op times were decreased in phase 2
(P= .073) and phase 3 (P= .049) compared with phase 1.WITs in
phase 2 and 3 were signiﬁcantly shorter than those in phase 1
(P= .048). EBL was signiﬁcantly smaller in phase 3 than in phase
1 (P= .049); however, there was no signiﬁcant difference in EBL
between phase 2 and phase 1.
Figures 3 and 4 shows the CUSUM learning curves of WIT and
EBL, respectively. Both of the curves consisted of 3 unique phases
with initial 7 cases of phase 1, and additional 7 cases (WIT) and
5 cases (EBL) in phase 2.4. Discussion
This is the ﬁrst study to investigate the learning curve for VAMS
partial nephrectomy. The learning curve is a graphic representa-
tion showing the relationship between the surgeon’s competence
and number of cases performed. The focus of this study was to
evaluate the surgeon’s operative competency based on 3
parameters, Op time, WIT, and EBL, and to divide the learning
curve into phases that correlate with the level of competency
achieved. We analyzed the learning curve using the CUSUM
technique. Statistical process-control methods such as the
CUSUM technique were ﬁrst used in pediatric cardiac surgery[11]
and are still used in monitoring the performance of cardiac
surgeons and the outcome of surgery.[13]
Previous studies have reported learning curves for RALPN and
LPN.[9–10,14] LPN, which is a challenging procedure, requires
considerable skill and expertise in techniques such as intracor-
poreal suturing with minimal ischemic times.[15] Even for
experienced laparoscopic surgeons, the learning curve (in terms
of Op time) for LPN is in the range of 100 to 150 cases.[16] The
introduction of robotic systems into partial nephrectomy
decreased the difﬁculty of intracorporeal suturing because of
the 6 degrees of freedom at the distal end of the instruments,
magniﬁed vision, scaled-down movement, and decreased trem-
or.[17–18] For surgeons already experienced with LPN, the
learning curve for RALPN is 16 cases, based on overall operative
time.[19]
In the present study, phase 1, the initial learning curve phase,
shows that after 7 cases, a surgeon with no prior experience in
partial nephrectomy could reach the learning phase in every
parameters of surgical performance. Over an additional 5 to 7
cases, comprising phase 2, the additional experience obtained led
to the achievement of expert competence. Compared with the
learning curves for LPN and RALPN, VAMS partial nephrec-
tomy has a shorter learning curve. This might be due to several
reasons. First, VAMS is a hybrid of open and laparoscopic
surgical technique. Whereas LPN and RALPN use needle drivers
that a novice may ﬁnd difﬁcult to handle, VAMS uses tools that
are typically used in open surgery, and are therefore familiar to
most surgeons who have basic training in open surgery. Second,
VAMS uses a telescope that has a magniﬁed view and an internal
light source. This enables the surgeon to have clear view of the
operative ﬁeld. Moreover, use of the telescope enables recording
of the procedure, which can then be used as an educational tool.
The surgeon in our study also reviewed the recordings for the
educational purposes before the ﬁrst surgery. In addition,
surgeons who are not familiar with laparoscopy can evaluate
the differences between the real operative ﬁeld, and the view of
the operative ﬁeld through the telescope. This is extremely
Figure 2. Total operation time (black) and CUSUMOT (blue line) plotted against case number; the red line represents the best ﬁt curve for the plot, which is a second-
order polynomial with the equation CUSUMOT=–1.24case number2+19.002case number+62.238 (R2=0.6098). Three phases were identiﬁed based on
total operation time in terms of the CUSUM learning curve. CUSUM = cumulative sum.
Table 2
Interphase comparisons of patient characteristics and other parameters.
Phase 1 Phase 2 Phase 3 P-value
(0–7, n=7) (8–12, n=5) (13–20, n=8)
Patient characteristics
Age, yr 50.3 (15.7) 58.2 (13.6) 56.0 (10.7) .562
Gender
Male 4 (57.1%) 5 (100%) 6 (75.0%) .283
Female 3 (42.9%) 0 (0.0%) 2 (25.0%)
Height, cm 163.8 (7.8) 168.6 (5.5) 167.5 (6.9) .449
Weight, kg 66.4 (9.7) 66.1 (9.3) 67.0 (7.2) .981
BMI, kg/m2 24.7 (2.4) 23.2 (2.9) 23.8 (0.9) .504
BSA, m2 1.7 (0.2) 1.8 (0.1) 1.8 (0.1) .87
ASA score
1 1 (14.3%) 1 (20.0%) 2 (25.0%) .492
2 5 (71.4%) 1 (20.0%) 3 (37.5%)
3 1 (14.3%) 3 (60.0%) 3 (37.5%)
HTN, n (%) 3 (42.9%) 2 (40.0%) 4 (50.0%) 1.000
DM, n (%) 3 (42.9%) 1 (20.0%) 1 (12.5%) .449
Kidney
Right 4 (57.1%) 1 (20.0%) 3 (37.5%) .537
Left 3 (42.9%) 4 (80.0%) 5 (62.5%)
RENAL score, mean 8.9 (1.7) 8.2 (0.8) 9.0 (1.3) .580
Intraoperative parameters
Op time, min 203.6 (50.0) 155.0 (23.2) 156.1 (34.5) .054
WIT, min 34.4 (9.0) 24.0 (2.9) 26.8 (6.9) .048
EBL, cc 360.0 (282.0) 126.0 (91.5) 97.5 (65.4) .120
Postoperative outcomes
Tumor size, cm 3.3 (1.1) 3.5 (0.5) 3.6 (1.0) .834
Pathology
Clear cell 7 (100.0%) 2 (40.0%) 7 (87.5%) .017
Papillary 0 (0.0%) 2 (40.0%) 0 (0.0%)
Chromophobe 0 (0.0%) 1 (20.0%) 0 (0.0%)
Multilocular cystic 0 (0.0%) 0 (0.0%) 1 (12.5%)
LOS, d 6.4 (2.1) 6.4 (3.1) 5.1 (1.2) .426
Data are shown as mean (SD) or number of subjects (%).
ASA=American Society of Anesthesiologists, BMI=body mass index, BSA=body surface area, DM=diabetes mellitus, EBL=estimated blood loss, HTN=hypertension, LOS= length of stay, Op=operation.
P-value calculated using ANOVA for continuous variables and chi-square test or Fisher exact test for categorical variables.
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Table 3
Laboratory measurements taken before the operation, immediately after the operation, and 1 d after the operation.
Phase 1 Phase 2 Phase 3
P-value(0–7, n=7) (8–12, n=5) (13–20, n=8)
Pre-Op Lab
WBC, /mL 8127.1 (1823.0) 7380.0 (1783.6) 6586.3 (1481.7) .236
RBC, 106/mL 4.5 (0.4) 4.6 (0.7) 4.7 (0.6) .758
Hb, g/dL 14.1 (1.3) 14.5 (1.7) 14.7 (2.2) .828
Hct (%) 42.2 (3.9) 42.7 (4.7) 43.7 (5.9) .829
Ca, mg/dL 9.5 (0.3) 9.2 (0.5) 9.3 (0.5) .541
P, mg/dL 3.6 (0.5) 3.7 (0.6) 3.3 (0.5) .302
Glucose, mg/dL 121.3 (48.4) 135.8 (68.2) 106.6 (17.5) .534
BUN, mg/dL 16.9 (7.0) 14.6 (2.9) 17.6 (4.8) .627
Creatinine, mg/dL 0.8 (0.2) 1.0 (0.1) 0.9 (0.2) .136
eGFR (MDRD), mL/min/1.73 m2 100.0 (23.5) 80.5 (15.1) 85.6 (18.9) .223
Uric acid, mg/dL 5.1 (1.3) 6.5 (0.5) 5.1 (1.4) .101
Cholesterol, mg/dL 184.4 (38.3) 178.8 (62.3) 187.9 (27.2) .930
AST, IU/L 16.9 (4.0) 29.4 (8.0) 21.3 (3.5) .002
ALT, IU/L 21.4 (13.3) 32.8 (10.9) 22.6 (11.3) .245
Immediate Post-Op Lab
WBC, /mL 15438.6 (3094.5) 13780.0 (3790.8) 14526.3 (3732.0) .723
RBC, 106/mL 3.8 (0.4) 4.2 (0.6) 4.1 (0.7) .556
Hb, g/dL 11.9 (1.1) 12.8 (1.7) 13.0 (2.4) .523
Hct (%) 35.4 (3.0) 39.2 (4.3) 38.9 (6.9) .359
Ca, mg/dL 7.6 (0.4) 8.2 (0.3) 7.7 (0.6) .111
P, mg/dL 3.0 (0.4) 3.1 (1.0) 3.1 (0.3) .046
Glucose, mg/dL 154.3 (30.8) 128.2 (30.0) 152.8 (47.5) .460
BUN, mg/dL 15.1 (5.2) 17.8 (5.3) 13.9 (3.8) .373
Creatinine, mg/dL 0.8 (0.1) 1.1 (0.1) 1.0 (0.2) .043
eGFR (MDRD), mL/min/1.73 m2 90.6 (19.0) 67.8 (6.1) 77.6 (12.8) .024
Uric acid, mg/dL 4.4 (0.9) 5.8 (0.8) 4.7 (1.1) .059
Cholesterol, mg/dL 132.7 (40.1) 159.6 (57.1) 160.3 (33.4) .428
AST, IU/L 18.7 (3.4) 30.4 (11.1) 26.6 (24.9) .478
ALT, IU/L 13.7 (4.6) 31.8 (10.6) 22.1 (14.0) .034
Post-Op Lab
WBC, /mL 12164.3 (1971.6) 10360.0 (2778.7) 10699.0 (2553.9) .383
RBC, 106/mL 3.8 (0.4) 4.0 (0.7) 4.0 (0.4) .590
Hb, g/dL 11.6 (1.1) 12.6 (1.9) 12.5 (1.2) .352
Hct (%) 34.7 (3.1) 37.6 (5.5) 37.6 (3.7) .329
Ca, mg/dL 7.9 (0.3) 8.3 (0.4) 7.8 (0.6) .259
P, mg/dL 3.2 (0.4) 3.7 (0.3) 3.3 (0.7) .016
Glucose, mg/dL 159.4 (47.4) 151.6 (40.3) 131.8 (54.8) .545
BUN, mg/dL 19.5 (7.3) 20.6 (5.2) 16.3 (2.8) .018
Creatinine, mg/dL 1.0 (0.2) 1.3 (0.1) 1.1 (0.3) .136
eGFR (MDRD), mL/min/1.73 m2 73.8 (16.9) 59.2 (7.6) 69.9 (17.1) .277
Uric acid, mg/dL 4.4 (1.0) 5.2 (0.7) 4.6 (1.3) .454
Cholesterol, mg/dL 140.0 (40.7) 163.0 (61.6) 152.5 (34.5) .690
AST, IU/L 24.1 (5.6) 33.2 (4.3) 28.6 (14.5) .331
ALT, IU/L 16.0 (4.8) 32.2 (8.9) 23.0 (13.1) .039
Data are shown as mean (SD).
ALT= alanine transaminase, AST= aspartate transaminase, BUN=blood urea nitrogen, Ca= calcium, Cr= creatinine, eGFR= estimated glomerular ﬁltration rate, Hb=hemoglobin, Hct=hematocrit, HDL-C=
high-density lipoprotein cholesterol, LDL-C= low-density lipoprotein cholesterol, MDRD=modiﬁcation of diet in renal disease, P=phosphorus, RBC= red blood cell, TC= total cholesterol, TG= triglyceride,
WBC=white blood cell.
P-value calculated using ANOVA.
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telescope and therefore the surgeon may be unfamiliar with
this view. In this way, the VAMS technique is not only a
surgical tool itself, but also an educational tool that enables
the surgeon to become familiar with laparoscopy. Third,
VAMS uses an extraperitoneal approach, which poses no risk
of bowel injury and has low morbidity. The surgeon can freely
perform the surgery without considering bowel injury, and
there is no need to consider adhesiolysis for patients with5bowel adhesions. Fourth, VAMS is cost-effective surgery
which does not require expensive equipment such as LPN and
RALPN. The tools used in VAMS is not expensive and most of
the tools are reusable.
VAMS has not been performed widely in partial nephrectomy
where renal masses are small; however, it has several advantages.
First, by getting real vision of the vascular structure, even when
the vascular structure is complex, surgeons could isolate renal
artery and vein more intuitively through direction vision. Second,
Figure 3. Warm ischemic time (black) and CUSUMWIT (blue line) plotted against case number; the red line represents the best ﬁt curve for the plot, which is a
second-order polynomial with the equation CUSUMWIT=–0.1618case number2+1.9719case number+20.233 (R2=0.5607). Three phases were identiﬁed
based on warm ischemic time in terms of the CUSUM learning curve. CUSUM = cumulative sum.
Park et al. Medicine (2019) 98:17 Medicineespecially if the mass is located at hilar, it is easier to isolate the
mass through using both the direct and endoscopic visions. Third,
VAMS could be performed regardless of the tumor location.
Fourth, retroperitoneal approach performed in VAMSminimizes
unnecessary dissection.
We annually perform about 80 cases of RALPN or LPN.
Although we prefer robot compared to laparoscopic methods,
it depends on ﬁnancial status of the patients since robot
surgeries are not ﬁnancially supported in Korean national
medical insurance system. We have performed open or VAMS
partial nephrectomy in cases where difﬁculty is expected or
patients with single kidney. Recently, in most cases, VAMS
has replaced open methods due to the many advantages
mentioned above.
As expected, the total Op time signiﬁcantly decreased after
phase 1, and the WIT was shorter and EBL was smaller in
phases 2 and 3 than in phase 1. This is probably due to the
increasing competence of the surgeon in the VAMS technique.
The mean WIT of LPN was 27.6minutes. Although no speciﬁc
methods were used to reduce case selection bias, the tumor sizes
were not different between phases, suggesting that no speciﬁc
phase contained cases that were particularly technically
challenging. Moreover, patient characteristics such as BMI
and BSA were not different between the phases. The RENAL
nephrometry score also showed no differences between phases6showing that there was no selection of easier cases at the start
of the learning curve which results in selection bias. The
procedure on kidney results in signiﬁcant decrease in kidney
function immediately after the operation due to the damage
during the operation; however, it was recovered after certain
period of time. This similar trend was also observed in LPN and
RALPN.[20,21]
This study has several limitations. First, this was limited
to a single-surgeon experience. Further studies including
multiple surgeons in different training experiences would
verify the learning curve results from our study. Second,
although there were no differences in cases between different
phases in our study, selection bias in the cases, if present,
could have affected the learning curve for VAMS partial
nephrectomy.
VAMS has advantages in partial nephrectomy by incorporat-
ing not only laparoscopic but also open surgical techniques
where a surgeon could achieve expert competence with
comparatively less time than other techniques. The reason that
VAMS has not been widely used is that not many surgeons
perform VAMS and its awareness is low. Therefore, we believe
that this study will increase the interests in this surgeon friendly
surgical approaches and increase the use of VAMS in partial
nephrectomy which are considered as one of the sophisticated
urological surgeries.
Figure 4. Estimated blood loss (black) and CUSUMEBL (blue line) plotted against case number; the red line represents the best ﬁt curve for the plot, which is a
second-order polynomial with the equation CUSUMEBL=–10.133case number2+204.13case number–164.53 (R2=0.7978). Three phases were identiﬁed
based on estimated blood loss in terms of the CUSUM learning curve. CUSUM = cumulative sum.
Park et al. Medicine (2019) 98:17 www.md-journal.com5. Conclusions
This study identiﬁed 3 unique phases of the learning curve for
VAMS partial nephrectomy using CUSUM analysis, showing
that after 12 cases, a surgeon can achieve expert competence,
with optimized WIT, total Op time, and EBL.Author contributions
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